1-4 of 4
Yazan Migdady, MD
Close
Sort by
Journal Articles

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Yazan Migdady, MD MSc, Ridhi Gupta, MBBS, Asiri Ediriwickrema, MD, Francisco Socola, MD, Sally Arai, MD, Beth A Martin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4976.
https://doi.org/10.1182/blood-2018-99-116560
Published: 2018
Journal Articles

Validation of the Prognostic Significance of Gene Expression Profiling (GEP) Analysis on Myeloma Irrespective of Disease Status or Stage - a Single Center Academic Center Experience -

Taiga Nishihori, MD, Rachid Baz, MD, Ram Thapa, PhD, Youngchul Kim, PhD, Dung-Tsa Chen, PhD, Yazan Migdady, MD, Ryan K Van Laar, PhD, Richard A Bender, MD, Erin M Siegel, PhD MPH, Vonetta Williams, PhD MPH, CTR, Michelle Fournier, Melissa Alsina, MD, Kenneth H. Shain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4417.
https://doi.org/10.1182/blood.V128.22.4417.4417
Published: 2016
Journal Articles

Promising Prognostic Values of Sequential Gene Expression Profiling in Multiple Myeloma Patients Undergoing Various Systemic Therapy

Yazan Migdady, MD MSc, Taiga Nishihori, MD, Rachid Baz, MD, Ram Thapa, PhD, Youngchul Kim, PhD, Dung-Tsa Chen, PhD, Ryan K Van Laar, PhD, Richard A Bender, MD, Siegel M Erin, PhD MPH, Vonetta Williams, PhD MPH, CTR, Michelle Fouriner, Melissa Alsina, MD, Kenneth H. Shain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5648.
https://doi.org/10.1182/blood.V128.22.5648.5648
Published: 2016
Journal Articles

Living In Remission: Disparities In Conditional Survival Among Non-Hodgkin Lymphoma Survivors

Yazan Migdady, MD, Mohammed Salhab, MD, Adam J. Olszewski, MD
Journal: Blood
Blood (2013) 122 (21): 2915.
https://doi.org/10.1182/blood.V122.21.2915.2915
Published: 2013